They identified MILR1 and FLT3 as pre-infusion biomarkers predictive of severe CRS and noted that CRS may be an IFNγ-driven process with a protein signature overlapping with hemophagocytic lymphohistiocytosis [6]. The gene discussed is MILR1; the disease is hemophagocytic syndrome.